Fenofibrate Capsules, USP 200 mg
Ajanta Pharma is recalling Fenofibrate Capsules, USP 200 mg, due to manufacturing process deviations.
Contact your healthcare provider or pharmacist if you have concerns about your medication. Do not stop taking prescribed medication without consulting a medical professional.
Why it was recalled
Ajanta Pharma is recalling Fenofibrate Capsules, USP 200 mg, due to current good manufacturing practice (CGMP) deviations. The affected product is packaged in 100-count bottles.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.
- Recall #
- D-0611-2026
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from Ajanta Pharma USA Inc
Editorial summary by Recall Canary · last updated 2026-06-23 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification